Tiber Creek Group on Behalf of Daiichi Sankyo, INC.
Global pharmaceutical company.
Based in DC
🤖
AI Overview
With $90K in lobbying spend across 4 quarterly filings, Tiber Creek Group on Behalf of Daiichi Sankyo, INC is an active lobbying client. Their lobbying covers 3 issue areas.
$90K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $90K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy
- •Issues related to drug pricing and reimbursement for prescription drugs; Issues related to orphan drugs.
- •Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).
- •Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
- •Issues related to drug pricing.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.